- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.20 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x 6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
- 3 x CDL: CARDIOLIPIN(Non-covalent)
CDL.3: 11 residues within 4Å:- Chain A: F.335, F.441, W.442, L.443, R.444
- Chain C: N.3, R.5, I.19, H.221
- Ligands: 6PE.2, PO4.13
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain A- Salt bridges: C:R.5, C:H.221, A:R.444
- Hydrogen bonds: A:L.443
CDL.16: 18 residues within 4Å:- Chain C: S.29, N.32, L.36, K.227, L.230, G.231
- Chain D: Y.219, K.222, R.223, K.230
- Chain F: R.61, Q.62
- Chain G: Y.28, I.33, N.35, V.36, R.39
- Ligands: CDL.23
11 PLIP interactions:4 interactions with chain G, 6 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: G:Y.28, G:I.33, D:Y.219, D:Y.219
- Hydrogen bonds: G:N.35, D:K.230
- Salt bridges: G:R.39, D:K.222, D:R.223, D:K.230, C:K.227
CDL.23: 10 residues within 4Å:- Chain C: S.28, S.29, W.30, M.96
- Chain F: Q.62
- Chain G: V.36, R.39, T.40
- Ligands: PEE.9, CDL.16
8 PLIP interactions:5 interactions with chain G, 1 interactions with chain F, 2 interactions with chain C- Hydrophobic interactions: G:V.36, G:T.40
- Hydrogen bonds: G:R.39, F:Q.62, C:S.29, C:S.29
- Salt bridges: G:R.39, G:R.39
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.4: 21 residues within 4Å:- Chain C: Q.44, I.45, G.48, L.49, L.51, A.52, R.80, H.83, A.84, A.87, F.90, T.126, A.127, G.130, Y.131, L.133, P.134, H.182, F.183, P.186, Y.273
14 PLIP interactions:14 interactions with chain C,- Hydrophobic interactions: C:Q.44, C:L.51, C:A.84, C:F.90, C:T.126, C:A.127, C:L.133, C:L.133, C:F.183, C:F.183
- Salt bridges: C:R.80, C:R.80
- Metal complexes: C:H.83, C:H.182
HEM.5: 24 residues within 4Å:- Chain C: W.31, G.34, S.35, L.37, G.38, F.90, L.94, H.97, V.98, R.100, S.106, F.109, T.112, W.113, G.116, V.117, L.119, L.120, H.196, L.197, L.200, S.205, N.206
- Ligands: I2Q.10
22 PLIP interactions:22 interactions with chain C,- Hydrophobic interactions: C:L.37, C:L.37, C:F.90, C:V.98, C:T.112, C:W.113, C:W.113, C:L.119, C:L.120, C:L.197, C:L.200, C:L.200
- Hydrogen bonds: C:G.34, C:S.106, C:N.206
- Water bridges: C:W.31, C:F.33
- Salt bridges: C:H.97, C:R.100, C:R.100
- Metal complexes: C:H.97, C:H.196
- 1 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 2 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
PEE.9: 16 residues within 4Å:- Chain C: W.30, Y.95, M.96, G.99, L.102, Y.103, Y.104, M.316, F.325, W.326, V.329, L.332
- Chain F: Q.62
- Chain G: C.43, V.47
- Ligands: CDL.23
14 PLIP interactions:13 interactions with chain C, 1 interactions with chain F- Hydrophobic interactions: C:W.30, C:W.30, C:L.102, C:Y.104, C:F.325, C:F.325, C:W.326, C:W.326, C:V.329, C:L.332
- Hydrogen bonds: C:Y.103, C:Y.103, C:Q.322, F:Q.62
PEE.20: 17 residues within 4Å:- Chain C: I.78, I.236, M.240
- Chain D: H.199, M.203, K.206, M.207, M.210, M.211
- Chain E: Y.49, A.50, A.51, N.53, V.54, Q.57
- Chain J: E.31, D.35
9 PLIP interactions:2 interactions with chain D, 4 interactions with chain E, 2 interactions with chain J, 1 interactions with chain C- Hydrophobic interactions: D:M.210, E:V.54, C:I.236
- Salt bridges: D:K.206
- Hydrogen bonds: E:Y.49, E:N.53, E:Q.57, J:E.31, J:D.35
- 1 x I2Q: 3-methyl-2-[4-[[4-(trifluoromethoxy)phenyl]methyl]phenyl]-1H-quinolin-4-one(Non-covalent)
I2Q.10: 16 residues within 4Å:- Chain C: A.17, F.18, L.21, I.27, S.35, G.38, I.42, M.190, M.194, L.197, H.201, S.205, F.220, D.228
- Ligands: HEM.5, DMS.11
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:F.18, C:I.27, C:I.42, C:L.197
- Hydrogen bonds: C:S.35
- pi-Stacking: C:F.18, C:F.220, C:F.220
- 1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 9 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.12: 8 residues within 4Å:- Chain C: A.327, A.330, D.331, T.334, L.357
- Chain G: P.50, A.53, F.54
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:P.50, G:F.54
PO4.13: 4 residues within 4Å:- Chain A: F.335, R.444
- Chain C: T.2
- Ligands: CDL.3
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:T.2
- Salt bridges: A:R.444
PO4.15: 3 residues within 4Å:- Chain D: W.11, E.123, R.190
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:E.123
- Salt bridges: D:R.190
PO4.19: 5 residues within 4Å:- Chain E: R.15, P.16, E.17
- Chain G: R.23
- Ligands: PO4.24
2 PLIP interactions:2 interactions with chain E- Water bridges: E:R.15, E:R.15
PO4.21: 2 residues within 4Å:- Chain F: P.41, Y.83
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:Y.83
PO4.22: 7 residues within 4Å:- Chain C: W.379
- Chain F: R.23, D.24, S.78, L.80, E.81, L.84
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:D.24, F:S.78, F:L.80
- Salt bridges: F:R.23
PO4.24: 4 residues within 4Å:- Chain G: R.23, A.24, F.25
- Ligands: PO4.19
3 PLIP interactions:3 interactions with chain G- Hydrogen bonds: G:A.24, G:F.25, G:F.25
PO4.25: 4 residues within 4Å:- Chain G: H.27, Y.28, F.29, S.30
3 PLIP interactions:3 interactions with chain G- Hydrogen bonds: G:H.27, G:F.29, G:S.30
PO4.26: 4 residues within 4Å:- Chain F: A.13
- Chain G: A.42, L.45, R.46
1 PLIP interactions:1 interactions with chain G- Salt bridges: G:R.46
- 1 x HEC: HEME C(Covalent)
HEC.14: 23 residues within 4Å:- Chain D: V.31, V.35, C.36, C.39, H.40, N.104, A.107, L.108, P.109, P.110, L.112, I.115, R.119, Y.125, V.126, L.129, L.130, F.152, I.157, G.158, M.159, P.162, V.185
21 PLIP interactions:21 interactions with chain D,- Hydrophobic interactions: D:V.31, D:V.35, D:N.104, D:A.107, D:P.109, D:P.110, D:L.112, D:I.115, D:V.126, D:L.129, D:L.130, D:L.130, D:I.157, D:M.159, D:P.162, D:V.185
- Hydrogen bonds: D:Y.125, D:Y.125, D:G.158
- Salt bridges: D:R.119
- Metal complexes: D:H.40
- 1 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 1 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PX4.18: 17 residues within 4Å:- Chain A: D.416, F.441, L.443
- Chain D: M.221
- Chain E: Y.37, T.40, T.43, T.44, V.47
- Chain J: F.13, R.14, T.16, F.19, A.20, I.23, V.24
- Ligands: 6PE.2
9 PLIP interactions:4 interactions with chain E, 2 interactions with chain A, 3 interactions with chain J- Hydrophobic interactions: E:T.43, E:V.47, J:A.20, J:I.23
- Hydrogen bonds: E:T.40
- pi-Cation interactions: E:Y.37, A:F.441, J:F.19
- Salt bridges: A:D.416
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Amporndanai, K. et al., Targeting the Ubiquinol-Reduction (Q i ) Site of the Mitochondrial Cytochrome bc 1 Complex for the Development of Next Generation Quinolone Antimalarials. Biology (Basel) (2022)
- Release Date
- 2022-08-10
- Peptides
- Cytochrome b-c1 complex subunit 1, mitochondrial: A
Cytochrome b-c1 complex subunit 2, mitochondrial: B
Cytochrome b: C
Cytochrome c1, heme protein, mitochondrial: D
Cytochrome b-c1 complex subunit Rieske, mitochondrial: E
Cytochrome b-c1 complex subunit 7: F
Cytochrome b-c1 complex subunit 8: G
Cytochrome b-c1 complex subunit 6, mitochondrial: H
Cytochrome b-c1 complex subunit Rieske, mitochondrial: I
Cytochrome b-c1 complex subunit 9: J - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
J - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.20 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x 6PE: 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)
- 3 x CDL: CARDIOLIPIN(Non-covalent)
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 2 x PEE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine(Non-covalent)
- 1 x I2Q: 3-methyl-2-[4-[[4-(trifluoromethoxy)phenyl]methyl]phenyl]-1H-quinolin-4-one(Non-covalent)
- 1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 9 x PO4: PHOSPHATE ION(Non-functional Binders)
- 1 x HEC: HEME C(Covalent)
- 1 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 1 x PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Amporndanai, K. et al., Targeting the Ubiquinol-Reduction (Q i ) Site of the Mitochondrial Cytochrome bc 1 Complex for the Development of Next Generation Quinolone Antimalarials. Biology (Basel) (2022)
- Release Date
- 2022-08-10
- Peptides
- Cytochrome b-c1 complex subunit 1, mitochondrial: A
Cytochrome b-c1 complex subunit 2, mitochondrial: B
Cytochrome b: C
Cytochrome c1, heme protein, mitochondrial: D
Cytochrome b-c1 complex subunit Rieske, mitochondrial: E
Cytochrome b-c1 complex subunit 7: F
Cytochrome b-c1 complex subunit 8: G
Cytochrome b-c1 complex subunit 6, mitochondrial: H
Cytochrome b-c1 complex subunit Rieske, mitochondrial: I
Cytochrome b-c1 complex subunit 9: J - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
J - Membrane
-
We predict this structure to be a membrane protein.